US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Reneuron Group Plc.

0.0000

0.0000

Volume:- -

Turnover:- -

Market Cap:57.17

PE:0.00

High:0.0000

Open:0.0000

Low:0.0000

Close:0.0000

52wk High:0.0011

52wk Low:0.0000

Shares:57.17M

Float Shares:46.43M

Volume Ratio:1.38

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1083

EPS(LYR):-0.1171

ROE:-106.77%

ROA:-37.91%

PB:0.00

PE(LYR):0.00

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Reneuron Group Plc.

Exchange:

EXPERT

Establishment Date:

1997

Employees:

26

Office Location:

Pencoed Business Park,Pencoed,Mid Glamorgan,United Kingdom

Website:

http://www.reneuron.com

Zip Code:

CF35 5HY

Phone:

44 20 3819 8400

Fax:

- -

Introduction:

ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized vesicles secreted by stem cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RNUGF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RNUGF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNUGF\",,,,,undefined,":{"symbol":"RNUGF","market":"US","secType":"STK","nameCN":"Reneuron Group Plc.","latestPrice":0.000001,"timestamp":1770930000000,"preClose":0.000001,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":46432348,"shares":57173800,"eps":-0.108288,"marketStatus":"Pre-Mkt","change":0,"latestTime":"02-12 16:00:00 EST Delay","open":0.000001,"high":0.000001,"low":0.000001,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.108288,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770993000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.000001,"volumeRatio":1.3806038931602524},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNUGF\",,,,,undefined,":{"symbol":"RNUGF","floatShares":46432348,"roa":"-37.91%","roe":"-106.77%","lyrEps":-0.117116,"volumeRatio":1.3806038931602524,"shares":57173800,"dividePrice":0,"high":0.000001,"amplitude":0,"preClose":0.000001,"low":0.000001,"week52Low":0.000001,"pbRate":"0.00","psRate":"0.00","week52High":0.0011,"institutionHeld":0,"latestPrice":0.000001,"eps":-0.108288,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.108288,"open":0.000001,"prevYearClose":0.000001,"prevWeekClose":0,"prevMonthClose":0,"prevQuarterClose":0,"fiveDayClose":0,"twentyDayClose":0,"sixtyDayClose":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNUGF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-30","symbol":"RNUGF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1717041600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2022-07-04","symbol":"RNUGF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1656907200000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2020-11-24","symbol":"RNUGF","defaultRemindTime":1606228200000,"type":"split","dateTimestamp":1606194000000,"forFactor":973684,"toFactor":1000000,"ratio":0.973684}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNUGF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RNUGF\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":125064,"yearFounded":1997,"employeeNum":26,"address":"Pencoed Business Park,Pencoed,Mid Glamorgan,United Kingdom","zipCode":"CF35 5HY","officePhone":"44 20 3819 8400"},"stockCompanyDetail":{"websiteUrl":"http://www.reneuron.com","stockEarnings":[{"period":"1week","weight":-0.3583},{"period":"1month","weight":-0.1858},{"period":"3month","weight":-0.3083},{"period":"6month","weight":-0.3224},{"period":"1year","weight":1.1684},{"period":"ytd","weight":2.4915}],"description":"ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized vesicles secreted by stem cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.","exchange":"EXPERT","name":"Reneuron Group Plc.","nameEN":"Reneuron Group Plc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"RNUGF\",market:\"US\",,,undefined,":null}}